A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations

被引:219
|
作者
Tamborero, David [1 ,2 ]
Rubio-Perez, Carlota [1 ,2 ]
Muinos, Ferran [2 ]
Sabarinathan, Radhakrishnan [2 ]
Piulats, Josep M. [3 ]
Muntasell, Aura [4 ]
Dienstmann, Rodrigo [5 ,6 ]
Lopez-Bigas, Nuria [1 ,2 ,7 ]
Gonzalez-Perez, Abel [1 ,2 ]
机构
[1] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona 08002, Spain
[2] Barcelona Inst Sci & Technol, Inst Res Biomed, Barcelona 08028, Spain
[3] CIBERONC, Dept Med Oncol, Inst Catala Oncol IDIBELL, Barcelona, Spain
[4] Hosp del Mar, Res Inst, Barcelona, Spain
[5] Vali dHebron Inst Oncol, Barcelona, Spain
[6] Sage Bionetworks, Seattle, WA USA
[7] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain
基金
美国国家卫生研究院; 欧洲研究理事会;
关键词
METASTATIC MELANOMA; ACQUIRED-RESISTANCE; TGF-BETA; IMMUNOTHERAPY; MICROENVIRONMENT; BLOCKADE; THERAPY; RESPONSES; EVASION; REVEAL;
D O I
10.1158/1078-0432.CCR-17-3509
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Throughout their development, tumors are challenged by the immune system, and they acquire features to evade its surveillance. A systematic view of these traits, which shed light on how tumors respond to immunotherapies, is still lacking. Experimental Design: Here, we computed the relative abundance of an array of immune cell populations to measure the immune infiltration pattern of 9,174 tumors of 29 solid cancers. We then clustered tumors with similar infiltration pattern to define immunophenotypes. Finally, we identified genomic and transcriptomic traits associated to these immunophenotypes across cancer types. Results: In highly cytotoxic immunophenotypes, we found tumors with low clonal heterogeneity enriched for alterations of genes involved in epigenetic regulation, ubiquitin-mediated proteolysis, antigen presentation, and cell-cell communication, which may drive resistance in combination with the ectopic expression of negative immune checkpoints. Tumors with immunophenotypes of intermediate cytotoxicity are characterized by an upregulation of processes involved in neighboring tissue invasion and remodeling that may foster the recruitment of immunosuppressive cells. Tumors with poorly cytotoxic immunophenotype tend to be of more advanced stages and bear a greater burden of copy number alterations and frequent alterations of cell cycle, hedgehog, beta-catenin, and TGF-beta pathways, which may cause immune depletion. Conclusions: We provide a comprehensive landscape of the characteristics of solid tumors that may influence (or be influenced by) the characteristics of their immune infiltrate. These results may help interpret the response of solid tumors to immunotherapies and guide the development of novel drug combination strategies. (C) 2018 AACR.
引用
收藏
页码:3717 / 3728
页数:12
相关论文
共 50 条
  • [1] Pan-cancer single cell landscape of tumor-infiltrating T cells
    Zheng, Liangtao
    Qin, Shishang
    Si, Wen
    Wang, Anqiang
    Xing, Baocai
    Gao, Ranran
    Ren, Xianwen
    Wang, Li
    Wu, Xiaojiang
    Zhang, Ji
    Wu, Nan
    Zhang, Ning
    Zheng, Hong
    Ouyang, Hanqiang
    Chen, Keyuan
    Bu, Zhaode
    Hu, Xueda
    Ji, Jiafu
    Zhang, Zemin
    [J]. SCIENCE, 2021, 374 (6574) : 1462 - +
  • [2] Landscape of RAS variations in 17993 solid tumors: A pan-cancer analysis.
    Wu, Hao
    Zhou, Shaoqiang
    Zhang, Ding
    Zhao, Jing
    Zhao, Zhengyi
    Wang, Guoqiang
    Zhang, Yuzi
    Cui, Longgang
    Cai, Shangli
    Bai, Yuezong
    Chen, Dedian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Landscape of IDH mutations in patients with solid tumors: A pan-cancer analysis.
    Guan, Xiaoxiang
    Zhu, Hong
    Zhang, Junling
    Yuan, Kai
    Shen, Dong
    Zhao, Jing
    Zhao, Zhengyi
    Cui, Longgang
    Zhang, Yuzi
    Wang, Guoqiang
    Cai, Shangli
    Bai, Yuezong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Landscape of infiltrating immune repertoire in pediatric solid tumors
    Nabbi, Arash
    Jaeger, Natalie
    Sudhaman, Sumedha
    Sun, Pengbo
    Yang, S. Y. Cindy
    Zhu, Kelsey
    Kool, Marcel
    Rathi, Komal
    Kalletla, Karthik
    Raman, Pichai
    Zhu, Yuankun
    Paulson, Joseph N.
    Jones, David T.
    Tabori, Uri
    Resnick, Adam C.
    Pfister, Stefan M.
    Pugh, Trevor J.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [5] Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment
    Varn, Frederick S.
    Wang, Yue
    Mullins, David W.
    Fiering, Steven
    Cheng, Chao
    [J]. CANCER RESEARCH, 2017, 77 (06) : 1271 - 1282
  • [6] Pan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors
    Saghafinia, Sadegh
    Mina, Marco
    Riggi, Nicolo
    Hanahan, Douglas
    Ciriello, Giovanni
    [J]. CELL REPORTS, 2018, 25 (04): : 1066 - +
  • [7] Pan-cancer whole genome analyses of metastatic solid tumors
    Cuppen, E.
    Priestley, P.
    Baber, J.
    Lolkema, M. P.
    Steeghs, N.
    de Bruijn, E.
    Duyvesteyn, K.
    Haidari, S.
    van Hoeck, A.
    Roepman, P.
    Shale, C.
    Voda, M.
    Tjan-Heijnen, V. C. G.
    Bloemendal, H.
    van Herpen, C.
    Labots, M.
    Witteveen, P. O.
    Smit, E. F.
    Sleijfer, S.
    Voest, E. E.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 864 - 864
  • [8] Landscape of IDH1/2 mutations in Chinese patients with solid tumors: A pan-cancer analysis
    Shen, Dong
    Zhang, Junling
    Yuan, Kai
    Zhao, Jing
    Zhao, Zhengyi
    Cui, Longgang
    Zhang, Yuzi
    Wang, Guoqiang
    Cai, Shangli
    Bai, Yuezong
    Li, Wei
    Huang, Xiang
    [J]. MOLECULAR GENETICS & GENOMIC MEDICINE, 2021, 9 (08):
  • [9] A Pan-Cancer Analysis of Tumor-Infiltrating B Cell Repertoires
    Yu, Katharine
    Ravoor, Akshay
    Malats, Nuria
    Pineda, Silvia
    Sirota, Marina
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [10] Pan-cancer landscape of abnormal ctDNA methylation across human tumors
    Bai, Yun
    Qu, Di
    Lu, Dan
    Li, Yiwen
    Zhao, Ning
    Cui, Guanghua
    Li, Xue
    Sun, Xiaoke
    Sun, Huaibo
    Zhao, Lihua
    Li, Qingyuan
    Zhang, Qi
    Han, Tiancheng
    Wang, Song
    Yang, Yu
    [J]. CANCER GENETICS, 2022, 268 : 1 - 9